Business Context and Reporting Period
Company: Alterity Therapeutics Limited (a development stage enterprise)
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: September 2026
Principal Executive Office: Level 15, 500 Collins Street, Melbourne, Victoria 3000, Australia
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. As a development stage enterprise, the document does not contain financial statements or specific financial data for the period.
Material Changes
No material financial changes versus a prior comparable period are reported in this filing. The document serves primarily to announce a corporate event.
Guidance, Outlook, and Management Commentary
- Corporate Event: The company will present at the Cantor Global Healthcare Conference (Exhibit 99.1).
- Registration Statements: This Form 6-K is incorporated by reference into Registration Statements on Form S-8 (Files No. 333-251073, 333-248980, 333-228671) and Form F-3 (Files No. 333-274816, 333-251647, 333-231417, 333-250076).
- Signatory: Signed by Julian Babarczy, Chairman, on September 3, 2026.
Investor Verification Checklist
- Verify the date and agenda of the upcoming presentation at the Cantor Global Healthcare Conference.
- Review the referenced Form S-8 and Form F-3 registration statements for details on equity offerings or employee stock plans.
- Confirm the company's current development stage status and lack of commercial revenue in subsequent filings.